Research Article

Comprehensive Evaluation of Gestational Diabetes Patients Against Exposure on PFAS and Its Derivatives: An Updated Systematical Review and Meta-Analysis

Volume: 55 Number: 2 September 23, 2025
EN

Comprehensive Evaluation of Gestational Diabetes Patients Against Exposure on PFAS and Its Derivatives: An Updated Systematical Review and Meta-Analysis

Abstract

Background and Aims: Gestational diabetes mellitus (GDM) is characterised by insulin resistance that first manifests during pregnancy. This study aimed to evaluate PFAS exposure as a risk factor for GDM. Methods: Descriptive Boolean queries were used to search PubMed, Scopus, and Web of Science for articles published between January 2015 to 2023 with “PFAS” OR “per- and polyfluoro alkyl” AND “gesta tional diabetes” keywords. A total of 10 studies were included. Results: There were no statistically significant difference between the patient and control groups for PFOS (MD = 0.36, 95% CI = [0.30, 1.02], Z=1.06, P=0.29), PFHxS (MD = −0.02, 95% CI = [−0.11, 0.07], Z=0.39, P=0.69), PFNA (MD = 0.00, 95% CI = [−0.02, 0.04], Z=0.10, P=0.92), PFHpA (MD = 0.01, 95% CI = [−0.00, 0.02], Z=1.63, P=0.10) and PFDA (MD = 0.00, 95% CI = [−0.03, 0.03], Z=0.15, P=0.88). A statistically significant difference was observed between the patient and control groups for PFOA (MD = 1.79, 95% CI = [0.99, 2.58], Z=4.42, P<0.001) and PFUnDA (MD = 0.10, 95% CI = [0.01, 0.19], Z=2.23, P=0.03). Conclusion: Our meta-analysis has shown a strong correlation between PFUnDA and PFOA levels in connection with GDM. A total of 10 randomised controlled trials (RCTs) were assessed to investigate the relationship between GDM and PFAS. Consistent with previous research, the presence of long-chain chemicals such as PFUnDA and PFOA may disrupt the normal functioning of β cells, leading to the development of GDM. These results can enhance future research on the relationship between GDM and hazardous exposures.

Keywords

References

  1. Armitage, J., Cousins, I. T., Buck, R. C., Prevedouros, K., Russell, M. H., MacLeod, M., & Korzeniowski, S. H. (2006). Modeling global-scale fate and transport of perfluorooctanoate emitted from direct sources. Environmental Science & Technology, 40(22), 6969-6975. https://doi.org/10.1021/es0614870 google scholar
  2. American Diabetes Association (ADA), (2018). 2. Classification and diagnosis of diabetes: standards of medical care in diabetes—2018. Diabetes Care, 41(Supplement_1), S13-S27. https://doi.org/10.2337/dc18-S002 google scholar
  3. Bellavia, A., Mínguez-Alarcón, L., Ford, J. B., Keller, M., Petrozza, J., Williams, P. L., Hauser, R., James-Todd, T., & Team, E. S. (2019). Association of self-reported personal care product use with blood glucose levels measured during pregnancy among women from a fertility clinic. Science of the Total Environment, 695, 133855. https://doi.org/10.1016/j.scitotenv.2019.133855 google scholar
  4. Biegel, L. B., Hurtt, M. E., Frame, S. R., O'Connor, J. C., & Cook, J. C. (2001). Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicological Sciences, 60(1), 44-55. https://doi.org/10.1093/toxsci/60.1.44 google scholar
  5. Birru, R. L., Liang, H.-W., Farooq, F., Bedi, M., Feghali, M., Haggerty, C. L., Mendez, D. D., Catov, J. M., Ng, C. A., & Adibi, J. J. (2021). A pathway level analysis of PFAS exposure and risk of gestational diabetes mellitus. Environmental Health, 20(1), 63. https://doi.org/10.1186/s12940-021-00740-z google scholar
  6. Buck, R. C., Franklin, J., Berger, U., Conder, J. M., Cousins, I. T., De Voogt, P., Jensen, A. A., Kannan, K., Mabury, S. A., & van Leeuwen, S. P. (2011). Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integrated Environmental Assessment and Management, 7(4), 513-541. https://doi.org/10.1002/ieam.258. google scholar
  7. Calafat, A. M., Kuklenyik, Z., Reidy, J. A., Caudill, S. P., Tully, J. S., & Needham, L. L. (2007). Serum concentrations of 11 polyfluoroalkyl compounds in the US population: data from the National Health and Nutrition Examination Survey (NHANES) 1999- 2000. Environmental Science & Technology, 41(7), 2237-2242. https://doi. org/10.1021/es062686m google scholar
  8. Casals-Casas, C., & Desvergne, B. (2011). Endocrine disruptors: from endocrine to metabolic disruption. Annual Review of Physiology, 73, 135-162. https://doi. org/10.1146/annurev-physiol-012110-142200 google scholar

Details

Primary Language

English

Subjects

Pharmaceutical Toxicology

Journal Section

Research Article

Publication Date

September 23, 2025

Submission Date

October 22, 2024

Acceptance Date

March 13, 2025

Published in Issue

Year 2025 Volume: 55 Number: 2

APA
Şahin Mazlumoğlu, B., Kaşali, K., Karagöl, N., Yücelik, Ş. S., & Senol, O. (2025). Comprehensive Evaluation of Gestational Diabetes Patients Against Exposure on PFAS and Its Derivatives: An Updated Systematical Review and Meta-Analysis. İstanbul Journal of Pharmacy, 55(2), 220-232. https://doi.org/10.26650/IstanbulJPharm.2025.1571818
AMA
1.Şahin Mazlumoğlu B, Kaşali K, Karagöl N, Yücelik ŞS, Senol O. Comprehensive Evaluation of Gestational Diabetes Patients Against Exposure on PFAS and Its Derivatives: An Updated Systematical Review and Meta-Analysis. iujp. 2025;55(2):220-232. doi:10.26650/IstanbulJPharm.2025.1571818
Chicago
Şahin Mazlumoğlu, Büşra, Kamber Kaşali, Nagihan Karagöl, Şaziye Sezin Yücelik, and Onur Senol. 2025. “Comprehensive Evaluation of Gestational Diabetes Patients Against Exposure on PFAS and Its Derivatives: An Updated Systematical Review and Meta-Analysis”. İstanbul Journal of Pharmacy 55 (2): 220-32. https://doi.org/10.26650/IstanbulJPharm.2025.1571818.
EndNote
Şahin Mazlumoğlu B, Kaşali K, Karagöl N, Yücelik ŞS, Senol O (September 1, 2025) Comprehensive Evaluation of Gestational Diabetes Patients Against Exposure on PFAS and Its Derivatives: An Updated Systematical Review and Meta-Analysis. İstanbul Journal of Pharmacy 55 2 220–232.
IEEE
[1]B. Şahin Mazlumoğlu, K. Kaşali, N. Karagöl, Ş. S. Yücelik, and O. Senol, “Comprehensive Evaluation of Gestational Diabetes Patients Against Exposure on PFAS and Its Derivatives: An Updated Systematical Review and Meta-Analysis”, iujp, vol. 55, no. 2, pp. 220–232, Sept. 2025, doi: 10.26650/IstanbulJPharm.2025.1571818.
ISNAD
Şahin Mazlumoğlu, Büşra - Kaşali, Kamber - Karagöl, Nagihan - Yücelik, Şaziye Sezin - Senol, Onur. “Comprehensive Evaluation of Gestational Diabetes Patients Against Exposure on PFAS and Its Derivatives: An Updated Systematical Review and Meta-Analysis”. İstanbul Journal of Pharmacy 55/2 (September 1, 2025): 220-232. https://doi.org/10.26650/IstanbulJPharm.2025.1571818.
JAMA
1.Şahin Mazlumoğlu B, Kaşali K, Karagöl N, Yücelik ŞS, Senol O. Comprehensive Evaluation of Gestational Diabetes Patients Against Exposure on PFAS and Its Derivatives: An Updated Systematical Review and Meta-Analysis. iujp. 2025;55:220–232.
MLA
Şahin Mazlumoğlu, Büşra, et al. “Comprehensive Evaluation of Gestational Diabetes Patients Against Exposure on PFAS and Its Derivatives: An Updated Systematical Review and Meta-Analysis”. İstanbul Journal of Pharmacy, vol. 55, no. 2, Sept. 2025, pp. 220-32, doi:10.26650/IstanbulJPharm.2025.1571818.
Vancouver
1.Büşra Şahin Mazlumoğlu, Kamber Kaşali, Nagihan Karagöl, Şaziye Sezin Yücelik, Onur Senol. Comprehensive Evaluation of Gestational Diabetes Patients Against Exposure on PFAS and Its Derivatives: An Updated Systematical Review and Meta-Analysis. iujp. 2025 Sep. 1;55(2):220-32. doi:10.26650/IstanbulJPharm.2025.1571818